Informations:
Erreur:
ID
12214
Description
Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing; ODM derived from: https://clinicaltrials.gov/show/NCT01868880
Lien
https://clinicaltrials.gov/show/NCT01868880
Mots-clés
Versions (1)
- 18/10/2015 18/10/2015 -
Téléchargé le
18 octobre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Heart Rate Control in ICD Patients With Heart Failure NCT01868880
Eligibility Heart Rate Control in ICD Patients With Heart Failure NCT01868880
- StudyEvent: Eligibility
Similar models
Eligibility Heart Rate Control in ICD Patients With Heart Failure NCT01868880
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
age
Item
age ≥ 18 years.
boolean
C0001779 (UMLS CUI [1])
chronic heart failure
Item
patients with stable chronic heart failure implanted with mono-cameral or bicameral icd with a home monitoring remote control.
boolean
C0264716 (UMLS CUI [1])
left ventricular dysfunction
Item
moderate to severe left ventricular dysfunction (fe ≤ 40%).
boolean
C0242698 (UMLS CUI [1])
Heart failure
Item
any cause of heart failure was allowed apart congenital heart disease.
boolean
C0018801 (UMLS CUI [1])
pacemaker
Item
bicameral icd programmed in ddd or aai/ddd with av interval < 300 msec.
boolean
C0030163 (UMLS CUI [1])
heart rate
Item
rest ecg heart rate ≥70 bpm;
boolean
C0018810 (UMLS CUI [1])
sinus rhythm.
Item
sinus rhythm.
boolean
C0232201 (UMLS CUI [1])
lipid-lowering therapy; angiotensin-converting enzyme inhibitor; beta-blocker
Item
in therapy with low-dose of beta-blocker (bisoprolol 1,25-2,5 mg) and with the maximum dose tolerated of angiotensin-converting enzyme inhibitor or blockade of angiotensin ii receptor, mineralocorticoid antagonist, antiplatelet and lipid-lowering therapy, unless contraindicated.
boolean
C0585943 (UMLS CUI [1])
C0003015 (UMLS CUI [2])
C0001645 (UMLS CUI [3])
C0003015 (UMLS CUI [2])
C0001645 (UMLS CUI [3])
informed consent
Item
inability of providing informed consent;
boolean
C0021430 (UMLS CUI [1])
age
Item
age < 18 years.
boolean
C0001779 (UMLS CUI [1])
pregnant; lactating
Item
state of pregnancy or lactation.
boolean
C0549206 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
C2828358 (UMLS CUI [2])
myocardial infarction
Item
recent (<2 months) myocardial infarction;
boolean
C0027051 (UMLS CUI [1])
contraindications; beta-blockers
Item
contraindications to beta-blockers and ivabradine;
boolean
C0683526 (UMLS CUI [1])
C0001645 (UMLS CUI [2])
C0001645 (UMLS CUI [2])
heart rate
Item
rest ecg heart rate < 70 bpm;
boolean
C0018810 (UMLS CUI [1])
sinus rhythm.
Item
no sinus rhythm.
boolean
C0232201 (UMLS CUI [1])
antiarrhythmic drugs
Item
administration of non-dihydropyridinic calcium channels antagonists, digitalis, class i antiarrhythmic drugs, strong inhibitors of cytochrome p450 3a4 at the time of enrollment.
boolean
C0003195 (UMLS CUI [1])